| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 08/11/2005 | WO2005072507A2 Biomarker detection in circulating cells |
| 08/11/2005 | WO2005072475A2 Itpks as modifiers of the igfr pathway and methods of use |
| 08/11/2005 | WO2005072470A2 Mbms as modifiers of branching morphogenesis and methods of use |
| 08/11/2005 | WO2005072457A2 Humoral response to hip1 in cancer |
| 08/11/2005 | WO2005072419A2 Gastrointestinal proliferative factor and uses thereof |
| 08/11/2005 | WO2005072388A2 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 08/11/2005 | WO2005072380A2 Membrane attack complexes associated with circulating immune complexes |
| 08/11/2005 | WO2005072341A2 Detection of mesothelin-/megakaryocyte potentiating factor-related peptides in peritoneal fluid for assessment of the peritoneum and the peritoneal cavity |
| 08/11/2005 | WO2005072314A2 Method and apparatus for evaluation of standing timber |
| 08/11/2005 | WO2005072272A2 Compositions and methods for generating short double-stranded rna using mutated rnase iii |
| 08/11/2005 | WO2005072270A2 Methods and compositons for treating cancer |
| 08/11/2005 | WO2005072263A2 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of mesothelioma |
| 08/11/2005 | WO2005072205A2 Image analysis and assay system |
| 08/11/2005 | WO2005072161A2 Apparatus and process for sensing target gas species in semiconductor processing systems |
| 08/11/2005 | WO2005072159A2 Biotherapeutics, diagnostics and research reagents |
| 08/11/2005 | WO2005072145A2 Methods and systems for point of care bodily fluid analysis |
| 08/11/2005 | WO2005072142A2 Hybrid nucleic acid assembly |
| 08/11/2005 | WO2005072112A2 Methods for producing and identifying multispecific antibodies |
| 08/11/2005 | WO2005072097A2 Toll-like receptor 9 modulators |
| 08/11/2005 | WO2005072066A2 Preventive or therapeutic agent for diabetic maculopathy |
| 08/11/2005 | WO2005066204A3 Neutralizing epitope-based growth enhancing vaccine |
| 08/11/2005 | WO2005064341A3 Methods for the in vitro diagnosis and in vitro prognosis of demyelinating diseases, and for the development of drugs against demyelinating diseases |
| 08/11/2005 | WO2005059170A3 Method for the determination of fibrinolytic activity in blood |
| 08/11/2005 | WO2005054849A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor mc5 (mc5r) |
| 08/11/2005 | WO2005050164A3 Detection systems and methods |
| 08/11/2005 | WO2005046617A3 Compositions and methods for reducing microbial induced apoptosis |
| 08/11/2005 | WO2005045438A3 METHOD FOR DISTINGUISHING AML SUBTYPE INV(3)(q21q26)/t(3;3)(q21q26) FROM OTHER AML SUBTYPES |
| 08/11/2005 | WO2005045434A3 Method for distinguishing aml subtypes with recurring genetic aberrations |
| 08/11/2005 | WO2005044963A3 High throughput screening methods for lubricating oil compositions |
| 08/11/2005 | WO2005043168A3 Method for distinguishing aml-specific flt3 length mutations from tkd mutations |
| 08/11/2005 | WO2005043161A3 Method for distinguishing leukemia subtypes |
| 08/11/2005 | WO2005042565A3 Cyclin groove inhibitors |
| 08/11/2005 | WO2005040788A3 Method for measuring oils or fats, filtering apparatus for oils or fats, and measuring device |
| 08/11/2005 | WO2005031357A3 Cell sample analysis |
| 08/11/2005 | WO2005026736A3 Diagnostics and therapeutics for diseases associated with organic cation transporter slc22a2 (slc22a2) |
| 08/11/2005 | WO2005020897A3 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 08/11/2005 | WO2005020886A3 Identification and use of cofactor independent phosphoglycerate mutase as a drug target |
| 08/11/2005 | WO2005019832A3 Quantification and site-specific profiling of protein phosphorylation |
| 08/11/2005 | WO2005019825A3 Secreted polypeptide species and use thereof |
| 08/11/2005 | WO2005015236A3 A method for predicting the progression of adenocarcinoma |
| 08/11/2005 | WO2005010483A3 Sensor arrangement |
| 08/11/2005 | WO2005002501A3 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 08/11/2005 | WO2004112698A3 Methods for obtaining anti-retroviral agents |
| 08/11/2005 | WO2004109540A3 A stochastic variable selection method for model selection |
| 08/11/2005 | WO2004108891A3 Methods for screening inhibitors of apoptosis |
| 08/11/2005 | WO2004101758A3 Composition for maintaining organ and cell viability |
| 08/11/2005 | WO2004099777A3 Multicoated or multilayer entrapment matrix for protein biosensor |
| 08/11/2005 | WO2004099376A3 Assays using amyloid precursor proteins with modified beta-secretase cleavage sites to monitor beta-secretase activity |
| 08/11/2005 | WO2004094602A3 Combinatorial surface chip compositions for selection, differentiation and propagation of cells |
| 08/11/2005 | WO2004090545A3 Methods for treating proliferative diseases and for monitoring the effectiveness of treatment of proliferative diseases |
| 08/11/2005 | WO2004088283A3 Apparatus and methods for providing sex-sorted animal sperm |
| 08/11/2005 | WO2004083819A3 Molecular forensic specimen marker |
| 08/11/2005 | WO2004083394A3 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 08/11/2005 | WO2004082635A3 Methods and compositions related to joint inflammation diseases |
| 08/11/2005 | WO2004066917A3 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/11/2005 | WO2004057014A3 Luminescent polymers and methods of use thereof |
| 08/11/2005 | WO2004056315A3 Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 08/11/2005 | WO2004050842A3 Atm kinase compositions and methods |
| 08/11/2005 | WO2004047721A3 A process for preparation of an agglutination reagent for rapid detection of typhoid |
| 08/11/2005 | WO2004039897A8 Process for making an electrochemical sensor |
| 08/11/2005 | WO2004030522A3 Diagnosis and monitoring of diseases |
| 08/11/2005 | WO2004012683A3 Novel druggable regions in set domain proteins and methods of using the same |
| 08/11/2005 | WO2004009766A3 Method of obtaining viable human liver cells, including hepatic stem/progenitor cells |
| 08/11/2005 | WO2004004662A3 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2005 | WO2004000009A3 Methods for selection for efficient animal growth |
| 08/11/2005 | WO2003077836A3 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 08/11/2005 | WO2003062446A3 Mrp9 and its use detecting and treating cancer |
| 08/11/2005 | WO2003035858A3 Bacterial polypeptides involved in nucleic acid processing |
| 08/11/2005 | WO2002012568A8 Cell-based analysis of high throughput screening data for drug discovery |
| 08/11/2005 | US20050177881 Using presence of allelic mutations in lysosomal acid lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) as diagnostic indicator of nervous system disorders |
| 08/11/2005 | US20050177876 Fcyriia transgenic animal model for autoimmune disease |
| 08/11/2005 | US20050177340 Method and system for real time reporting of boiler adjustment using emission sensor data mapping |
| 08/11/2005 | US20050177317 Measuring and analyzing multi-dimensional sensory information for indentification purposes |
| 08/11/2005 | US20050177316 Algorithm for estimating and testing association between a haplotype and quantitative phenotype |
| 08/11/2005 | US20050177315 Feature extraction of partial microarray images |
| 08/11/2005 | US20050177313 Method, device and computer program for selecting an intraocular lens for an aphakic eye that has previously been subjected to refractive surgery |
| 08/11/2005 | US20050177309 Method and probe for measuring hydraulic conductivity of soil |
| 08/11/2005 | US20050177196 Methods and apparatus for identifying patients at risk for life threatening arrhythmias |
| 08/11/2005 | US20050177134 Device for dosing substances |
| 08/11/2005 | US20050177070 Urine sample collection device |
| 08/11/2005 | US20050177056 Breath collection system |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176935 Dna dependent protein kinase catalytic subunit phosphorylation sites and antibodies thereto |
| 08/11/2005 | US20050176931 Eotaxin : eosinophil chemotactic cytokine |
| 08/11/2005 | US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176826 Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| 08/11/2005 | US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176691 Combination therapy for the treatment of estrogen-sensitive disease |
| 08/11/2005 | US20050176683 Hexa-/Tetra-hydro-pyrrolo[1,2-a]imidazole-2,5-dione derivatives; solid phase synthesis |
| 08/11/2005 | US20050176660 Use of specific antisense-based constructs and peptide-specific polyclonal and monoclonal antibodies in leukemia, acute or chronic tissue damages, HIV-related damage of brain or other tissues, skeletal muscle disorders, transplantation rejection; Parkinson's disease; amyotrophic lateral sclerosis |
| 08/11/2005 | US20050176659 Polypeptide contributing to regulating the metabolism of triglycerides; obesity as well as related disorders such as eating disorder, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, dyslipidemia, osteoarthritis, gallstone, cancers of the reproductive organs |
| 08/11/2005 | US20050176649 complexing apoptosis protein with a labeled compound to form a complex having the measurable feature; contacting the labeled compound/IAP complex with the test agent; measuring displacement of the complex; drug screening; anticarcinogenic agent |
| 08/11/2005 | US20050176642 Enhancing anti-HIV efficiency through multivalent inhibitors targeting oligomeric GP120 |
| 08/11/2005 | US20050176637 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 08/11/2005 | US20050176626 modulating production of neurons and/or oligodendrocytes from neural progenitor cells of human white matter and to a method of treating a subject for a condition modulated by underproduction of oligodendrocytes from human white matter, sterol inhibitors |
| 08/11/2005 | US20050176584 Mehtod for high throughput screening of plant growth regulator |
| 08/11/2005 | US20050176158 Process for analyzing the tear fluid |
| 08/11/2005 | US20050176157 Using protein migration patterns as tool in characterizing and identifying immunoglobulins with preferential disulfide linkage patterns |